373 results on '"Chazouillères, O."'
Search Results
2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
3. HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry
4. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
5. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
6. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
7. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
8. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance
9. Cholangite sclérosante
10. Prévalence et impact pronostique des comorbidités respiratoires chez les patients candidats à une transplantation hépatique
11. Features, prognosis and management of primary biliary cirrhosis in the era of ursodeoxycholic acid
12. Les manifestations hépatobiliaires au cours des MICI
13. HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy
14. Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study
15. A New Clinical Condition Linked to a Novel Mutation in Lamins A and C with Generalized Lipoatrophy, Insulin-Resistant Diabetes, Disseminated Leukomelanodermic Papules, Liver Steatosis, and Cardiomyopathy
16. Chronic cholestatic diseases
17. CHRONIC CHOLESTATIC LIVER DISEASES ARE ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
18. Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with Primary Sclerosing Cholangitis
19. C16/10 RESPONSE TO IV PULSED HIGH DOSE CORTICOSTEROID THERAPY OF PRIMARY BILIARY CIRRHOSIS (PBC) RESISTANT TO URSODEOXYCHOLIC ACID (UDCA)
20. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
21. Sofosbuvir plus ribavirin and sofosbuvir plus daclatasvir-based regimens are suboptimal in genotype 2 patients: real-life experience
22. Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
23. Refinement of diagnostic criteria and frequency estimation of LPAC syndrome: A French multicenter study
24. NGM282, an engineered analogue of FGF19, significantly improves markers of bile acid synthesis, hepatic injury and fibrosis in PSC patients: Results of a phase 2, multicenter, randomized, doubleblind, placebo-controlled trial
25. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
26. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
27. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
28. Cas clinique : prise en charge des cholestases chroniques
29. A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
30. P.04.19 FROM GUIDELINES TO UNIFORM PAN-HEALTHCARE PROFESSIONAL PRACTICE: DEVELOPMENT OF AN INTERNATIONAL CONSENSUS CARE PATHWAY FOR THE DIAGNOSIS AND MANAGEMENT OF PRIMARY BILIARY CHOLANGITIS
31. Fibroscan and MRI Have Complementary Prognostic Values in Primary Sclerosing Cholangitis
32. Fibroscan Improves the Ability of the New Prognostic Scoring Systems to Predict Outcomes of Pbc
33. Liver Stiffness Measurement by Transient Elastography for the Prediction of Fibrosis in Patients with Primary Sclerosing Cholangitis in a Randomized Trial of Simtuzumab
34. Perturbations du bilan hépatique chez les patients hospitalisés pour poussée de psoriasis : prévalence et facteurs associés
35. Magnetic resonance cholangiography and biochemical predictive criteria of response to endoscopic treatment of severe strictures in patients with primary sclerosing Cholangitis
36. From guidelines to uniform pan-healthcare professional practice: development of an international consensus Care Pathway for the diagnosis and management of Primary Biliary Cholangitis (PBC)
37. Two simple magnetic resonance scores are able to predict survival in patients with Primary Sclerosing Cholangitis
38. SAT-031 - Refinement of diagnostic criteria and frequency estimation of LPAC syndrome: A French multicenter study
39. THU-300 - Sofosbuvir plus ribavirin and sofosbuvir plus daclatasvir-based regimens are suboptimal in genotype 2 patients: real-life experience
40. LBO-002 - NGM282, an engineered analogue of FGF19, significantly improves markers of bile acid synthesis, hepatic injury and fibrosis in PSC patients: Results of a phase 2, multicenter, randomized, doubleblind, placebo-controlled trial
41. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
42. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
43. P1148 : Long-term administration of ursodeoxycholic acid prevents recurrence of primary biliary cirrhosis after liver transplantation
44. P1175 : Ability of a simple radiologic score, assessed by three-dimensional Magnetic Resonance Cholangiography (MRC), to predict clinical outcome of patients with Primary Sclerosing Cholangitis (PSC)
45. P1266 : Human albumin use in cirrhotic patients in France: Results of the national “Albu-live” survey
46. LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*
47. O84 LIVER STIFFNESS ASSESSED BY FIBROSCAN IS A MAJOR PROGNOSTIC FACTOR IN PRIMARY SCLEROSING CHOLANGITIS
48. P364 CHARACTERIZATION AND OUTCOME OF ANTIMITOCHONDRIAL TYPE 2-POSITIVE PATIENTS WITHOUT A DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS: A FRENCH NATIONWIDE PROSPECTIVE STUDY
49. SAT-372 - Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis
50. FRI-375 - Liver Stiffness Measurement by Transient Elastography for the Prediction of Fibrosis in Patients with Primary Sclerosing Cholangitis in a Randomized Trial of Simtuzumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.